$SAGE Sage Therapeutics, Inc. Insider Trading Week 29/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sage Therapeutics, Inc. in week 29/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | See Remarks | Buy | P | 18.00 | 6,000 | 108,000 | 98,063 | 92.1 K to 98.1 K (+6.52 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 885,583 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 281,137 | 0 | 4,249,389 | 4 M to 4.2 M (+7.08 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 2,380,951 | 0 | 3,968,252 | 1.6 M to 4 M (+150.00 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,587,301 | 0 | 1,587,301 | 0 to 1.6 M |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Director | Buy | P | 18.00 | 10,000 | 180,000 | 803,650 | 793.7 K to 803.7 K (+1.26 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 18.00 | 4,000 | 72,000 | 226,222 | 222.2 K to 226.2 K (+1.80 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Buy | P | 18.00 | 6,000 | 108,000 | 6,000 | 0 to 6 K |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | P | 18.00 | 6,000 | 108,000 | 6,000 | 0 to 6 K |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 885,583 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 281,137 | 0 | 4,249,389 | 4 M to 4.2 M (+7.08 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,380,951 | 0 | 3,968,252 | 1.6 M to 4 M (+150.00 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,587,301 | 0 | 1,587,301 | 0 to 1.6 M |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 295,194 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,499,999 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 93,712 | 0 | 11,681,008 | 11.6 M to 11.7 M (+0.81 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 793,650 | 0 | 11,587,296 | 10.8 M to 11.6 M (+7.35 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 10,317,457 | 0 | 10,793,646 | 476.2 K to 10.8 M (+2,166.67 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 295,194 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 2,499,999 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | C | 0.00 | 93,712 | 0 | 11,681,008 | 11.6 M to 11.7 M (+0.81 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | C | 0.00 | 793,650 | 0 | 11,587,296 | 10.8 M to 11.6 M (+7.35 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | C | 0.00 | 10,317,457 | 0 | 10,793,646 | 476.2 K to 10.8 M (+2,166.67 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Director | Buy | P | 18.00 | 5,000 | 90,000 | 5,000 | 0 to 5 K |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | P | 18.00 | 3,000 | 54,000 | 3,000 | 0 to 3 K |